These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26434594)

  • 1. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.
    Fan SJ; Snell C; Turley H; Li JL; McCormick R; Perera SM; Heublein S; Kazi S; Azad A; Wilson C; Harris AL; Goberdhan DC
    Oncogene; 2016 Jun; 35(23):3004-15. PubMed ID: 26434594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino acid transporter SLC36A4 regulates the amino acid pool in retinal pigmented epithelial cells and mediates the mechanistic target of rapamycin, complex 1 signaling.
    Shang P; Valapala M; Grebe R; Hose S; Ghosh S; Bhutto IA; Handa JT; Lutty GA; Lu L; Wan J; Qian J; Sergeev Y; Puertollano R; Zigler JS; Xu GT; Sinha D
    Aging Cell; 2017 Apr; 16(2):349-359. PubMed ID: 28083894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.
    Goberdhan DC; Wilson C; Harris AL
    Cell Metab; 2016 Apr; 23(4):580-9. PubMed ID: 27076075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4.
    Matsui T; Fukuda M
    EMBO Rep; 2013 May; 14(5):450-7. PubMed ID: 23478338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dennd3 functions as a guanine nucleotide exchange factor for small GTPase Rab12 in mouse embryonic fibroblasts.
    Matsui T; Noguchi K; Fukuda M
    J Biol Chem; 2014 May; 289(20):13986-95. PubMed ID: 24719330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation.
    Heublein S; Kazi S; Ogmundsdóttir MH; Attwood EV; Kala S; Boyd CA; Wilson C; Goberdhan DC
    Oncogene; 2010 Jul; 29(28):4068-79. PubMed ID: 20498635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target?
    Goberdhan DC
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1360-7. PubMed ID: 21154118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab1A is an mTORC1 activator and a colorectal oncogene.
    Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
    Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC38A9: A lysosomal amino acid transporter at the core of the amino acid-sensing machinery that controls MTORC1.
    Rebsamen M; Superti-Furga G
    Autophagy; 2016 Jun; 12(6):1061-2. PubMed ID: 26431368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino acid transporter SLC38A9 regulates MTORC1 and autophagy.
    Jin M; Klionsky DJ
    Autophagy; 2015; 11(10):1709-10. PubMed ID: 26506891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
    Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
    Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9.
    Jung J; Genau HM; Behrends C
    Mol Cell Biol; 2015 Jul; 35(14):2479-94. PubMed ID: 25963655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.
    Rebsamen M; Pochini L; Stasyk T; de Araújo ME; Galluccio M; Kandasamy RK; Snijder B; Fauster A; Rudashevskaya EL; Bruckner M; Scorzoni S; Filipek PA; Huber KV; Bigenzahn JW; Heinz LX; Kraft C; Bennett KL; Indiveri C; Huber LA; Superti-Furga G
    Nature; 2015 Mar; 519(7544):477-81. PubMed ID: 25561175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
    Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
    Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors.
    Faes S; Duval AP; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Demartines N; Dormond O
    Mol Cancer; 2016 Dec; 15(1):78. PubMed ID: 27919264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas.
    Grzmil M; Huber RM; Hess D; Frank S; Hynx D; Moncayo G; Klein D; Merlo A; Hemmings BA
    J Clin Invest; 2014 Feb; 124(2):742-54. PubMed ID: 24401275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.
    Dodd KM; Yang J; Shen MH; Sampson JR; Tee AR
    Oncogene; 2015 Apr; 34(17):2239-50. PubMed ID: 24931163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.